These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7556953)

  • 1. Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo.
    Hagström-Toft E; Bolinder J; Eriksson S; Arner P
    Diabetes; 1995 Oct; 44(10):1170-5. PubMed ID: 7556953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man.
    Enoksson S; Degerman E; Hagström-Toft E; Large V; Arner P
    Diabetologia; 1998 May; 41(5):560-8. PubMed ID: 9628274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man.
    Moberg E; Enoksson S; Hagström-Toft E
    Horm Metab Res; 1998 Nov; 30(11):684-8. PubMed ID: 9918386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ regulation of lipolysis by insulin and norepinephrine: a microdialysis study during euglycemic-hyperinsulinemic clamp.
    Cimmino M; Agosto A; Minaire Y; Géloën A
    Metabolism; 1995 Dec; 44(12):1513-8. PubMed ID: 8786716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion.
    Cheung P; Yang G; Boden G
    Metabolism; 2003 Nov; 52(11):1496-500. PubMed ID: 14624413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phosphodiesterase inhibition with amrinone or theophylline on lipolysis and blood flow in human adipose tissue in vivo as measured with microdialysis.
    Arner P; Hellmér J; Hagström-Toft E; Bolinder J
    J Lipid Res; 1993 Oct; 34(10):1737-43. PubMed ID: 8245724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique.
    Flechtner-Mors M; Jenkinson CP; Alt A; Biesalski HK; Adler G; Ditschuneit HH
    J Physiol Pharmacol; 2005 Sep; 56(3):355-68. PubMed ID: 16204759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginseng extract inhibits lipolysis in rat adipocytes in vitro by activating phosphodiesterase 4.
    Wang H; Reaves LA; Edens NK
    J Nutr; 2006 Feb; 136(2):337-42. PubMed ID: 16424109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin.
    Navegantes LC; Sjöstrand M; Gudbjörnsdottir S; Strindberg L; Elam M; Lönnroth P
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5515-20. PubMed ID: 14602799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin on human adipose tissue metabolism in situ. Interactions with beta-adrenoceptors.
    Hagström-Toft E; Arner P; Johansson U; Eriksson LS; Ungerstedt U; Bolinder J
    Diabetologia; 1992 Jul; 35(7):664-70. PubMed ID: 1322851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 10 days of endurance exercise training on the suppression of whole body and regional lipolysis by insulin.
    Hickner RC; Racette SB; Binder EF; Fisher JS; Kohrt WM
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1498-504. PubMed ID: 10770188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans.
    Stumvoll M; Jacob S; Wahl HG; Hauer B; Löblein K; Grauer P; Becker R; Nielsen M; Renn W; Häring H
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3740-5. PubMed ID: 11061533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men.
    Stich V; Pelikanova T; Wohl P; Sengenès C; Zakaroff-Girard A; Lafontan M; Berlan M
    Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E599-607. PubMed ID: 12900381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of whole body and regional lipolysis by insulin: effects of obesity and exercise.
    Hickner RC; Racette SB; Binder EF; Fisher JS; Kohrt WM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3886-95. PubMed ID: 10566624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
    Kather H; Scheurer A
    Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo.
    Bertin E; Arner P; Bolinder J; Hagström-Toft E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1229-34. PubMed ID: 11238513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute peripheral tissue effects of ghrelin on interstitial levels of glucose, glycerol, and lactate: a microdialysis study in healthy human subjects.
    Vestergaard ET; Møller N; Jørgensen JO
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1273-80. PubMed ID: 23592479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional difference in lipolysis caused by a beta-adrenergic agonist as determined by the microdialysis technique.
    Iwao N; Oshida Y; Sato Y
    Acta Physiol Scand; 1997 Dec; 161(4):481-7. PubMed ID: 9429655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of the Trp64Arg beta 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue.
    Snitker S; Odeleye OE; Hellmér J; Boschmann M; Monroe MB; Shuldiner AR; Ravussin E
    Diabetologia; 1997 Jul; 40(7):838-42. PubMed ID: 9243106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.